ESR1 and breast carcinoma: While specific miRNAs may be postulated to regulate the expression of genes involved in receptor networks known to drive breast cancer progression, miRNA profiling has not yet been shown capable of independently identifying breast cancer phenotypes clinically defined by the overexpression of ErbB2 and/or estrogen receptor (ER) proteins.